life science investing MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
life science investing MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
Kobo Resources to Recommence 2025 Drill Program at the Kossou Gold Project; Appoints Industry Veteran to Support Technical and Regional Growth Strategy
